BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 10915493)

  • 1. Medical device reporting: another final rule, Part I.
    Donawa M
    Med Device Technol; 2000 Mar; 11(2):40-2. PubMed ID: 10915493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical device reporting: the US final rule.
    Donawa ME
    Med Device Technol; 1996 Mar; 7(2):14-6, 18, 20-1. PubMed ID: 10159867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical device reporting: another final rule, Part II.
    Donawa M
    Med Device Technol; 2000 Apr; 11(3):30-2. PubMed ID: 10947329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. U.S. medical device reporting: who is responsible?
    Donawa M
    Med Device Technol; 2005 Apr; 16(3):27-9. PubMed ID: 15871421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. US regulation of combination products.
    Donawa M
    Med Device Technol; 2009 Oct; 20(6):22, 24-5. PubMed ID: 20302139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding US labelling requirements.
    Donawa M
    Med Device Technol; 2005 Sep; 16(7):21-3. PubMed ID: 16259155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meeting European and US requirements for design and development documentation, Part II.
    Donawa ME
    Med Device Technol; 1996 Dec; 7(10):10-5. PubMed ID: 10164052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Final FDA inspection manual.
    Donawa M
    Med Device Technol; 2001 Apr; 12(3):29-32. PubMed ID: 11547684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New US agent requirements.
    Donawa M
    Med Device Technol; 2002; 13(1):35-7. PubMed ID: 11921780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Working draft of the FDA GMP final rule (Part II).
    Donawa ME
    Med Device Technol; 1995 Nov; 6(9):9-12. PubMed ID: 10158131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meeting US and European supplier control requirements.
    Donawa M
    Med Device Technol; 2009; 20(3):24-7. PubMed ID: 19626952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The US medical device bundling policy.
    Donawa M
    Med Device Technol; 2004 Nov; 15(9):25-7. PubMed ID: 16231784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complying with US nonconforming product requirements.
    Donawa M
    Med Device Technol; 2007; 18(3):22, 24-5. PubMed ID: 17585716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical device reporting for user facilities.
    Radiol Manage; 1992; 14(4):65-70. PubMed ID: 10123092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDA pilot programme in support of global harmonisation.
    Donawa ME
    Med Device Technol; 2003 Nov; 14(9):32-4. PubMed ID: 14682021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Working draft of the FDA GMP final rule (Part I).
    Donawa ME
    Med Device Technol; 1995 Oct; 6(8):13-22. PubMed ID: 10158125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical devices; procedures for investigational device exemptions--Food and Drug Administration. Final rule.
    Fed Regist; 1980 Jan; 45(13):3732-59. PubMed ID: 10248822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. US quality system requirements for software validation.
    Donawa ME
    Med Device Technol; 1998 Mar; 9(2):17-20. PubMed ID: 10186973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful recruitment for medical device clinical studies.
    Donawa M
    Med Device Technol; 2004 Oct; 15(8):25-7. PubMed ID: 16225270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical devices; medical device reporting. Direct final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2005 Feb; 70(38):9516-28. PubMed ID: 15736310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.